Neurotrophic growth factors are polypeptides that pro mote trophic effects on neuronal cells by acting through specific receptors. Brain-derived neurotrophic factor (BDNF) and the biologically similar nerve growth factor are related members of the neurotrophin family of growth factors. These neurotrophins act on a set of high affinity receptor kinases to promote survival, differentia tion, and neurite extension in many types of mammalian central nervous system neurons (Lamballe et ai., 1991; Kaplan et ai., 1991). Acting through the receptor tyrosine kinase (TrkB), BDNF is more widely distributed throughout the central nervous system than nerve growth Received October 17, 1996; final revision received February 3, 1997; accepted February 4, 1997.
Neurotrophic growth factors are polypeptides that pro mote trophic effects on neuronal cells by acting through specific receptors. Brain-derived neurotrophic factor (BDNF) and the biologically similar nerve growth factor are related members of the neurotrophin family of growth factors. These neurotrophins act on a set of high affinity receptor kinases to promote survival, differentia tion, and neurite extension in many types of mammalian central nervous system neurons (Lamballe et ai., 1991; Kaplan et ai., 1991) . Acting through the receptor tyrosine kinase (TrkB), BDNF is more widely distributed throughout the central nervous system than nerve growth test). There were no significant differences in weight in BDNF treated animals and controls during the experiment. After elec tive killing on day 7 after MCAO, brains underwent 2,3,5-triphenyltetrazolium chloride staining for calculation of the in farct volume and for histology (hematoxylin and eosin and glial fibrillary acid protein). The mean total infarct volume was 83.1 ± 27.1 mm3 in BDNF-treated animals and 139.2 ± 56.4 mm3 in controls (mean ± SD; P < 0.0 I, unpaired, two-tailed t-test). The cortical infarct volume was 10.8 ± 7.1 mm' in BDNF-treated animals and 37.9 ± 19.8 mm3 in controls (mean ± SD; P < 0.05; unpaired, two-tailed t-test), whereas ischemic lesion volume in caudoputaminal infarction was not significantly different.
These results show that pretreatment with intraventricular BDNF reduces infarct size after focal cerebral ischemia in rats and support the hypothesis of a neuroprotective role for BDNF in stoke. Key Words: Brain-derived neurotrophic factor Neurotrophins-Focal cerebral ischemia-MCAO-His tology.
factor and seems to have an additional paracrine or au tocrine function (Lindsay, 1995) . In vitro BDNF displays trophic effects on a wide range of neuronal cells, includ ing hippocampal, cerebellar, and cortical neurons (Em fors et ai., 1990; Hohn et aI., 1990; Hyman et ai., 1991; Ebendal, 1992; Ip et ai., 1993; Lindholm et aI., 1993; Shimohama et ai., 1993; Roback et ai., 1995) . In vivo, BDNF rescues motoneurons and substantia nigral dopa minergic cells from traumatic and toxic brain injury (Op penheim et ai., 1992; Sendtner et aI., 1992; Tsukahara et ai., 1995) . Transient forebrain ischemia induces BDNF mRNA upregulation in the hippocampus (Lindvall et ai., 1992; Tsukahara et ai., 1994) and correlates with pre vention of hippocampal neuronal death in BDNF-treated rats (Tsukahara et ai. 1994 , Beck et a1.1994 . After middle cerebral artery occlusion (MCAO), BDNF mRNA upregulation in the cortex seems to correlate with resistance to injury in this area (Kokaia et ai., 1995) . Exogeneous administration of BDNF may support this effect and minimize brain damage after ischemic injury.
BRAIN-DERIVED NEUROTROPHIC FACTOR REDUCES INFARCT SIZE

Sal
Because of the reported neuroprotective effects of BDNF in vitro and in vivo and the possible role of BDNF in focal cerebral ischemia, we hypothesize that intraven tricular administration of BDNF may reduce infarct vol ume and improve behavioral outcome in a model of per manent MCAO in rats. In this study, we administered intraventricular BDNF for 8 days, starting 1 day before MCAO and assessed the effects on neurological out come, infarct volume, and histological findings.
MATERIALS AND METHODS
Male Wistar rats weighing 300-315 g were allowed to have food and water as desired. All animals were randomly assigned before surgery for 2,3,5-triphenyltetrazolium chloride (TTC) staining or histology in one of the following groups: BDNF treated group (n = 13), placebo-treated group (n = 13), or sham-operated group (n = 3). The rats were then weighed and anesthetized intraperitoneally with chloral hydrate (400 mg/ kg). The left femoral artery was cannulated with PE-50 poly ethylene tubing for continuous monitoring of arterial blood pressure and blood sampling for analysis of arterial blood gases. Core temperature was maintained at 36.9 to 37.2°C dur ing surgery using a heating lamp connected to a rectal tem perature probe. Cranial temperature was recorded using a small and a small machine screw inserted in the skull. Dental cement was used for fixation of the pump on the skull and connected to the screw for stability. Sham-operated animals underwent the same experimental procedures as described above but screws and minipump were not implanted. The wound was closed with a 3-0 silk suture.
After 24 hours, permanent occlusion of the middle cerebral artery (MCA) was induced using the suture occlusion technique (ZeaLonga et aI., 1989; Schabitz et aI., 1996) . The right com mon carotid artery and the right external carotid artery were exposed briefly through a midline neck incision. A 4-0 mono filament nylon suture (Ethicon, Germany) coated with silicon (Bayer, Germany) was inserted through an arteriectomy in the eommon carotid artery, gently advanced into the internal cartotid artery, and positioned approximately 17 mm from the carotid bifurcation. Using this technique, the tip of the suture occludes unilaterally the proximal anterior cerebral artery, the origins of the MCA, and the posterior communicating artery. A large infarct in the territory of the MCA is typically produced (ZeaLonga et aI., 1989; Minematsu et aI., 1992) . Sham operated animals underwent the same experimental procedures as described above but the nylon filament was just inserted in the common carotid artery and not advanced. After surgery, the catheters were removed, and the animals were allowed to re cover from the anesthesia and given food and water as desired.
After ischemia was induced, the animals were weighed and neurologically assessed daily (rating scale: 0 = no deficit to 4 = spontaneous circling) (Menzies et aI., 1992) . On the seventh day animals were reanesthetized with chloral hydrate (400 mg/ kg) and decapitated. The brains were removed and the appro priate location of the intra-arterial suture was confirmed. The brains were then coronally sectioned into five 2-mm coronal slices, incubated for 30 minutes in a 2% solution of TTC at For histological study, animals (n = 3 per group) were trans cardially perfusion fixed with 4% paraformaldehyde in 0.1 mol/L phosphate buffer. The brains were removed from the skull, allowed to fix overnight in 4% paraformaldehyde at 4°C and then sectioned at the level of the anterior commissure, hippocampus, and substantia nigra. Slices of 10 [Lm were ob tained from paraffin blocks and stained with hematoxylin and eosin. Other sections from these brains were cut at 30 [Lm and immunostained for glial fibrillary acid protein using the avidin biotin peroxidase complex method (Garcia et al. 1993) . Hema toxylin and eosin stained brain sections and a corresponding TTC-stained brain slice at the level of the anterior commisure were compared for extent of striatal and cortical infarct volume blinded to the treatment given (M.S.). Hematoxylin and eosin and glial fibrillary acid protein-stained brain sections were then inspected for morphology.
The values presented in this study are mean ± SO. After acquiring all the data, the randomization code was broken.
Volumes of infarction between groups were compared by an unpaired, two-tailed t-test. Continuous data were analyzed by analysis of variance and Scheffe's-test.
RESULTS
Permanent intra-arterial suture occlusion of the MCA causes large infarcts of the lateral cortex and the under lying caudoputamen in the ipsilateral hemisphere (Garcia et aI., 1993) . In this study the mean infarct volume was smaller (ca. 40%) in BDNF-treated animals than in con trols (P < 0.01; unpaired, two-tailed t-test) ( treated animals versus controls (P < 0.05, unpaired, two tailed t-test), whereas caudoputaminal infarction was re duced ca. 25% (N.S.), (Table 1) .
There were no significant differences in the physi ological parameters during surgery between BDNF treated animals and controls (Table 2 ). There was less neurological deficit after ischemia in the BDNF-treated animals than in the controls (P < 0.05; analysis of vari ance and Scheffe's test) (Table 3 ). There were no sig nificant differences in weight loss among the infarcted animals; qowever weight increased significantly in sham-operated animals as compared with infarcted ani mals (P < 0.001; analysis of variance and Scheffe's test) (Table 4) . One animal in the BDNF-treated group and 2 animals in the control group died 24 to 48 hours after MCAO with signs of massive brain edema and were discarded from the experiment.
Extent of striatal and cortical infarction in hematoxy lin and eosin-stained brains correlated with correspond ing TTC-stained brain sections in both groups. The isch emic lesion, clearly discernible from the surrounding brain, involved the basal ganglia, a portion of the thala mus, and part of the cortex. Pan-necrosis and reabsorp tion were most prominent in the supraoptic area. Red and ghost neurons, ghost astrocytes, and infiltration by in flammatory cells were found in particular at the margins of the lesion in both groups. Infarcts were, on average, smaller in BDNF-treated animals than in controls. In particular, cortical infarctions appeared visibly smaller in BDNF-treated animals. Moreover, examination of hema toxylin and eosin-and glial fibrillary acid protein-stained brain sections showed no apparent differences in vascu lar or glial proliferation at the borders of the ischemic lesion in BDNF-treated animals and controls. Examina tion of hematoxylin and eosin-and glial fibrillary acid protein-stained brain sections in sham-operated animals showed no abnormal histologic findings.
DISCUSSION
The results of this study show for the first time that continuous treatment with intraventricularly adminis tered BDNF for I day before and 7 days after ischemia reduced infarct volume and improved neurological out come in a model of permanent MCAO in rats. The infarct volume was smaller in the cortex than in the caudoputa men.
BRAIN-DERIVED NEUROTROPHIC FACTOR REDUCES INFARCT SIZE
The dose of BDNF chosen for the current studies (in traventricular administration, 2.1 J..L g/d) was higher than that used in previous studies of transient forebrain isch emia (Tsukahara et aI. , 1995; Beck et a!. , 1994) to maxi mize any potential infarct-reducing effects. Even with this relatively high dose no significant side effects were observed. In the present study, intraventricular BDNF administration was started 1 day before and continued 7 days after MCAO. Although the rate of BDNF delivery was controlled (0.087 J..L g/h) , we do not know the exact concentration and distribution of BDNF delivered to the ischemic cortex. In healthy brains intraventricular BDNF poorly penetrates the ventricular wall into the surround ing parenchyma (Yan et a!., 1994; Dittrich et aI. , 1996) . However, no data are available for distribution of BDNF under traumatical conditions such as MCAO. The suture occlusion of the MCA causes ischemia of the ipsilateral periventricular brain structures (preoptical region, basal ganglia, thalamus) within minutes, whereas infarction of the cortex occurs later (Garcia et a!. , 1993) . Brain derived neurotrophic factor might penetrate the trauma tized peri ventricular wall and diffuse into the parenchyma. For intrastriatal injection, retrograde transport of BDNF was found within regions known to project to the striatum, such as the frontoparietal cortex, rhomboid, centrolateral, ventrolateral, parafascicular, posterior tha lamic areas as well as the pars compacta of the substantia nigra (Mufson et a!., 1994) .
Protective effects after administration of neurotrophic factors (e.g. , BDNF) were observed both in vitro and in vivo after various brain insults. In cell culture, BDNF ameliorates degeneration of hippocampal neurons caused by glutamate (Cheng et aI. , 1994) . Brain-derived neuro trophic factor also protects cultured dentate granule cells and hippocampal, striatal, septal, and cortical neurons against a hypoglycemic insult, evoked by glucose depri vation (Cheng et aI. , 1991; Cheng et a!. , 1994; Lindholm et al., 1993; Shimohama et a!., 1993; Kokaia et al., 1994; Nakao et a!. , 1995) . Exogeneous administration of BDNF in vivo was shown to ameliorate neuronal necro sis after ischemic insults (Beck et aI. , 1994; Tsukahara et aI. , 1994) . The mechanisms for the neuroprotective ca pability of BDNF that cause infarct reduction in focal cerebral ischemia are still unclear.
Glucose deprivation and excitotoxicity with subse quent Ca 2 + overload of cells as well as apoptosis and decreased energy reserve in the face of increased require- ) 38.2 ± 9 37.0 ± 7.4 42.1 ± 8.5 p0 2 (mm Hg) 90.7 ± 10 94.3 ± 11.4 92.1 ± 12.2 MABP (mm Hg) 90.2 ± 17.8 94.1 ± 14.6 93.4 ± 11 Body temperature (0C) 36.9 ± 0.55 37.0 ± 0.63 37 ± 0.1 Cranial temperature e C) 36.3 ± 0.31 36.7 ± 0.18 36. 9 ± 0.1
Data are mean ± SD. Differences in physiological variables between groups were not statistically significant (P > 0.05; analysis of variance and Scheffe's-test). BDNF, brain-derived neurotrophic factor; MABP, mean arterial bood pressure; MCAO, middle cerebral artery occlusion. Values are mean ± SD. The neurological score was significantly lower in BDNF-treated animals than in controls (P < 0.05; analysis of variance and Scheffe's-test). BDNF, brain-derived neurotrophic factor.
ments (e. g. , from spreading depression) are the main causes of, neuronal cell death after ischemia Hossmann, 1994; Li et aI. , 1995) . Brain derived neurotrophic factor protects in vitro neuronal cells against glutamate induced neurotoxicity and the subsequent high intracellular calcium level (Lindholm et aI., 1993; Cheng et aI. , 1994) . However, another study showed that treatment by neurotrophins, including BDNF, increased Ca 2 + uptake and potentiated the ne crotic death of cortical neurons induced by oxygen glucose deprivation or N-methyl-D-aspartate exposure (Koh et aI., 1995) . In contrast, in the same study BDNF also attenuates apoptotic cell death induced by serum deprivation or exposure to the calcium-channel antago nist nimodipine. The necrosis-potentiating effect may be caused, at least in part, by increased NMDA receptor mediated Ca 2 + influx. Implying a more sophisticated mechanism Koh et al. (1995) hypothesized that increased concentrations of intracellular free Ca 2 + is beneficial to cells undergoing apoptosis, but may also be detrimental to cells already overloaded with Ca 2 + because of excito toxic NMDA receptor overstimulation (Koike et aI. , 1989; Hartley et aI. , 1993; Morelli et aI. , 1986) .
In focal cerebral ischemia, critical blood flow rates determine the penumbra, a coronal region intercalated between the necrotic infarct core and the normal brain. This region comprises all tissues that have a cerebral blood flow that is sufficiently reduced so as to put the cells at risk. Penumbral tissues have higher flow rates and can be salvaged by recirculation or by drugs admin istered either before or during the first hours of MCAO (Memezawa et aI., 1992; Hossmann, 1994) . Recently, apoptotic cell death after MCAO was defined to the pen umbral border of the infarction, where cells are not so rapidly and severely damaged that they can undergo an appropriate cell death rather than necrosis (Li et aI. , 1995 a,b) . Presence and anatomical location of cells showing DNA fragmentation after transient MCAO suggests that apoptosis contributes to the development of the ischemic infarct (Hsu et aI., 1993) . Brain-derived neurotrophic factor attenuates in vitro apoptosis (Koh et aI., 1995) and it may be speculated that a possible prevention of apop tosis by BDNF in vivo contributes to, at least in part, the reduction of infarct size. Moreover, the neuroprotective action of BDNF may depend on neuronal gene transcrip tion and protein synthesis particularly at the margins of focal infarcts. Middle cerebral artery occlusion induces the expression of immediate early genes (c-fos, c-jun) and transcription factors (AP-l) that may activate growth factor gene transcription (Kaku et aI. , 1993; Kokaia et aI. , 1995) . A BDNF upregulation was found after MCAO in the cortex and the penumbra of the ischemic hemi sphere and seems to correlate with resistance to injury in these areas (Kokaia et aI., 1995) . Exogenous administra tion of BDNF may support this endogenous effect and reduce infarct size through direct interaction in these mechanisms.
The present study does not include measurements on CBF and we can not exclude that BDNF may have af fected CBF. For other growth factors (e.g. , basic fibro blast growth factor), an effect on CBF after topical ap plication has been reported. Basic fibroblast growth fac tor causes a dilation of brain pial arterioles, increases CBF, thereby reduces infarct volume after focal cerebral ischemia. (Rosenblatt et aI. , 1995; Tanaka et aI. , 1995) .
Another possible mechanism of BDNF-induced reduc tion in infarct size might be a protection of the degrada tion of cytoskeletal proteins. Glutamate release and the subsequent Ca 2 + overload of neuronal cells caused by ischemia activate calpain-induced proteolysis of the cy toskeletal proteins neurofilament and microtubule associated protein, the major component of microtubules (Tanaka et aI. , 1994; Black et aI. , 1986) . Neurotrophins, and particularly nerve growth factor, promote stability Data are mean ± SD. Day 1 indicates day after minipump implantation, before MCAO. Weight between infarcted animals was not significantly different. Weight increased significantly in sham-operated animals as compared with BDNF-treated and controls (P < 0.00 I; analysis of variance and Scheffe' s-test). BDNF, brain-derived neurotrophic factor; MCAO, middle cerebral artery occlusion. and fonnation of microtubules and inhibit degradation of microtubules through activation of microtubule associated-protein (Hofer and Barde 1988) . Although not completely understood, BDNF might have a function similar to that of nerve growth factor in this system (Hofer and Barde, 1988; Ebendal, 1992) .
No changes in physiological parameters such as MABP, blood gases, and body and cranial temperature were seen between treated groups during surgery, al though we cannot· exclude such changes during preop erative or postoperative periods. No differences in weight were seen between BDNF-treated animals or con trols during this relatively short experiment. However, BDNF-treated animals with reduced brain damage should suffer from less loss of weight after ischemia than controls. This possible effect may be hidden by BDNF induced weight loss after central infusion (Lapchak et al., 1992; Pelleymounter et al., 1994; Dittrich et al., 1996) .
Weight loss during central infusion of BDNF occurred in brains that were not pathologically altered and may re flect a central appetite suppression perhaps through a hypothalamic seretonergic mechanism (Lapchak et al., 1992; Pelleymounter et al., 1994) . Unfortunately, weight behavior during pathophysiological (e.g., ischemic) con ditions was not reported (Beck et al., 1994; . 
